GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » DNA Chip Research Inc (TSE:2397) » Definitions » Gross Margin %

DNA Chip Research (TSE:2397) Gross Margin % : 5.24% (As of Dec. 2023)


View and export this data going back to 2004. Start your Free Trial

What is DNA Chip Research Gross Margin %?

Gross Margin % is calculated as gross profit divided by its revenue. DNA Chip Research's Gross Profit for the three months ended in Dec. 2023 was 円5.6 Mil. DNA Chip Research's Revenue for the three months ended in Dec. 2023 was 円106.6 Mil. Therefore, DNA Chip Research's Gross Margin % for the quarter that ended in Dec. 2023 was 5.24%.


The historical rank and industry rank for DNA Chip Research's Gross Margin % or its related term are showing as below:

TSE:2397' s Gross Margin % Range Over the Past 10 Years
Min: -10.86   Med: 20.62   Max: 32.27
Current: 6.02


During the past 13 years, the highest Gross Margin % of DNA Chip Research was 32.27%. The lowest was -10.86%. And the median was 20.62%.

TSE:2397's Gross Margin % is ranked worse than
92.99% of 214 companies
in the Medical Diagnostics & Research industry
Industry Median: 45.595 vs TSE:2397: 6.02

DNA Chip Research had a gross margin of 5.24% for the quarter that ended in Dec. 2023 => No sustainable competitive advantage

The 5-Year average Growth Rate of Gross Margin for DNA Chip Research was 0.00% per year.


DNA Chip Research Gross Margin % Historical Data

The historical data trend for DNA Chip Research's Gross Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

DNA Chip Research Gross Margin % Chart

DNA Chip Research Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Gross Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 27.68 24.79 20.39 20.85 -10.86

DNA Chip Research Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Gross Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -32.48 22.25 -29.18 4.53 5.24

Competitive Comparison of DNA Chip Research's Gross Margin %

For the Diagnostics & Research subindustry, DNA Chip Research's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


DNA Chip Research's Gross Margin % Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, DNA Chip Research's Gross Margin % distribution charts can be found below:

* The bar in red indicates where DNA Chip Research's Gross Margin % falls into.



DNA Chip Research Gross Margin % Calculation

Gross Margin is the percentage of Gross Profit out of sales or Revenue.

DNA Chip Research's Gross Margin for the fiscal year that ended in Mar. 2023 is calculated as

Gross Margin % (A: Mar. 2023 )=Gross Profit (A: Mar. 2023 ) / Revenue (A: Mar. 2023 )
=-35.6 / 327.535
=(Revenue - Cost of Goods Sold) / Revenue
=(327.535 - 363.113) / 327.535
=-10.86 %

DNA Chip Research's Gross Margin for the quarter that ended in Dec. 2023 is calculated as


Gross Margin % (Q: Dec. 2023 )=Gross Profit (Q: Dec. 2023 ) / Revenue (Q: Dec. 2023 )
=5.6 / 106.625
=(Revenue - Cost of Goods Sold) / Revenue
=(106.625 - 101.041) / 106.625
=5.24 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


DNA Chip Research  (TSE:2397) Gross Margin % Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

DNA Chip Research had a gross margin of 5.24% for the quarter that ended in Dec. 2023 => No sustainable competitive advantage


Be Aware

If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.


DNA Chip Research Gross Margin % Related Terms

Thank you for viewing the detailed overview of DNA Chip Research's Gross Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


DNA Chip Research (TSE:2397) Business Description

Traded in Other Exchanges
N/A
Address
1-1-43 Suehirocho, Tsurumi-ku, Yokohama, JPN
DNA Chip Research Inc is specializing in the development of DNA microarrays. Its major business is focused on research and development, contract research service, and diagnostic support service. The company provides a wide variety of analytical services, from DNA chips to state-of-the-art next-generation sequencing. In addition, it provides consultation on experimental planning, sample preparation, statistical analysis, and manuscript preparation, catering to researchers' needs and requirements.

DNA Chip Research (TSE:2397) Headlines

No Headlines